It has been observed that in patients with co-morbid conditions involving NF-κB hyperactivity such as HIV infection, hyper-IgE syndrome, rheumatoid arthritis, multiple myeloma, and inflammatory bowel disease, there is an increased risk for the development of osteoporosis (Ginaldi et al., 2005). Here, NFKB1 is linked to inflammatory bowel disease.